TeaRx is Pharmaceuticals in Russia that focus on pulmonary embolism business. Founded in 2011. They cover business area such as developer, therapeutic drug, deep venous thrombosis, DVT, pulmonary embolism, PE, anticoagulant, blood coagulation factor Xa inhibitor, thioredoxin molecule, treatment, disease, surgical procedure, medical institution, thromboembolism, patient, life.
2011
( 13 years old in 2024 )
Pulmonary Embolism
-
Khimki 2-d, Rabochaya Street
Building 1
Moscow, 141400
Russia
Private
developertherapeutic drugdeep venous thrombosisDVTpulmonary embolismPEanticoagulantblood coagulation factor Xa inhibitorthioredoxin moleculetreatmentdiseasesurgical proceduremedical institutionthromboembolismpatientlife
* We use standard office opening hours in near TeaRx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
TeaRx is Pharmaceuticals business from Russia that founded in 2011 (13 years old in 2024), TeaRx business is focusing on Pulmonary Embolism.
TeaRx headquarter office and corporate office address is located in Khimki 2-d, Rabochaya Street Building 1 Moscow, 141400 Russia.
TeaRx was founded in Russia.
In 2024, TeaRx is currently focus on pulmonary embolism sector.
Above is snippet of Google Trends for "pulmonary embolism" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with TeaRx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
